ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
“Southern Africa must be innovative to tackle access to HIV and TB treatment” says ARASA
The right to life is being denied due to high prices for medicines. Addressing pharmaceuticals’ abuse of intellectual property law...
BLOG: 39 developing countries excluded from optimal HIV treatment – a dangerous oversight or deliberate tactic?
This World AIDS Day (1 December 2017), we’re pleased to have reached a point where more people are set to...
São Paulo protest exposes how Gilead’s actions block access to medicines around the world
In São Paulo, on 31 October 2017, activists from around the world held a protest at the headquarters of...
Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
Symposium in Curitiba highlights the need for a collective fight to make medicines affordable. When governments are unreceptive, it is...
Malaysia paves the way for compulsory licensing on hepatitis C medicines
Historic decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Tackling the hepatitis C epidemic in Malaysia
With new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
Seminar: Policies around Access to Medicines & Human Rights
Watch the presentations of the "Sustainability, Health Systems and Human Rights" at the Seminar on Policies of Access to Medicines and Human Rights.
Want to Improve Access to ARVs?
Sign up for your chance to learn how to challenge intellectual property barriers, that impede access to affordable medicines.
Civil Society Advocates for Intellectual Property Law Reform in Ukraine
The All-Ukrainian Network of People Living with HIV (Network) advocate for change of law to improve access to medicines, in...